Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Axsome Therapeutics, Inc. (AXSM)
Sector: Healthcare; Industry: Biotechnology

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the phase III clinical trial for the treatment resistant depression and depressive disorders; and phase II/III clinical trials in agitation associated with Alzheimer's disease, as well as completed phase II clinical trial for the treatment of smoking cessation. The company was founded in 2012 and is based in New York, New York.

AXSM Symbol Info by TradingView

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-11-19 JEFFS ROGER Director Buy 3,950 $37.30 $147,350 No
2021-11-18 Pizzie Nick CHIEF FINANCIAL OFFICER Buy 955 $35.26 $33,676 No
2021-11-18 Coleman Mark Director Buy 1,430 $35.09 $50,181 No
2021-11-17 Saad Mark E Director Buy 3,300 $34.52 $113,922 No
2021-05-12 Coleman Mark Director Buy 500 $58.15 $29,075 No
2020-06-29 Coleman Mark Director Buy 650 $78.50 $51,025 No
2020-06-29 Pizzie Nick Chief Financial Officer Buy 777 $76.64 $59,549 No
2019-09-26 Pizzie Nick Chief Financial Officer Buy 2,180 $24.80 $54,064 No
2019-06-26 Coleman Mark Director Buy 16,200 $23.10 $374,280 No
2019-06-11 Pizzie Nick Chief Financial Officer Buy 1,920 $20.80 $39,936 No
2019-05-23 Saad Mark E Director Buy 3,500 $22.33 $78,155 No
2019-05-13 Coleman Mark Director Buy 4,650 $21.44 $99,696 No
2019-03-19 Pizzie Nick Chief Financial Officer Buy 5,400 $12.58 $67,939 No
2019-03-19 Coleman Mark Director Buy 5,100 $12.18 $62,118 No
2018-06-19 Pizzie Nick Chief Financial Officer Buy 31,000 $3.10 $96,080 No
2015-12-23 Kaye Randall Chief Medical Officer Buy 1,000 $9.03 $9,026 No

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.